{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:08Z","timestamp":1792791428174,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11543-1","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:03:35Z","timestamp":1773147815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical significance of miR-146a-5p and miR-192-5p expression in relation to disease activity and immunobiochemical markers in systemic lupus erythematosus"],"prefix":"10.1007","volume":"53","author":[{"given":"Mohamed M.","family":"Sadaty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"El-Zayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma M","family":"Mekhemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"El-Ansary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla O","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"11543_CR1","unstructured":"Song Y, Li J, Wu Y Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders. Signal Transduction and Targeted Therapy 2024 9:1 [Internet]. 2024 Oct 4 [cited 2025 Aug 8];9(1):1\u201340. Available from: https:\/\/www.nature.com\/articles\/s41392-024-01952-8"},{"key":"11543_CR2","doi-asserted-by":"crossref","unstructured":"Dai X, Fan Y, Zhao X Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics. Signal Transduct Target Ther [Internet]. 2025 Dec 1 [cited 2025 Oct 8];10(1):102. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11914703\/","DOI":"10.1038\/s41392-025-02168-0"},{"key":"11543_CR3","doi-asserted-by":"crossref","unstructured":"Suszek D, Dubaj M, Bigosi\u0144ski K, Dembowska A, Kaniewski M, Sielwanowska W et al Usefulness in daily practice of the Systemic Lupus Erythematosus Disease Activity Index 2000 scale and the Systemic Lupus Erythematosus Disease Activity Score index for assessing the activity of systemic lupus erythematosus. Reumatologia [Internet]. 2024 [cited 2025 Aug 8];62(3):187. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11267658\/","DOI":"10.5114\/reum\/190257"},{"key":"11543_CR4","doi-asserted-by":"crossref","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol (Lausanne) [Internet]. 2018 Aug 3 [cited 2025 Oct 8];9(AUG):402. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6085463\/","DOI":"10.3389\/fendo.2018.00402"},{"key":"11543_CR5","doi-asserted-by":"crossref","unstructured":"Singh RP, Massachi I, Manickavel S, Singh S, Rao NP, Hasan S et al (2013) The role of miRNA in inflammation and autoimmunity. Autoimmun Rev [Internet]. Oct [cited 2025 Dec 9];12(12):1160\u20135. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23860189\/","DOI":"10.1016\/j.autrev.2013.07.003"},{"key":"11543_CR6","doi-asserted-by":"crossref","unstructured":"Gayosso-G\u00f3mez LV, Ortiz-Quintero B Circulating MicroRNAs in Blood and Other Body Fluids as Biomarkers for Diagnosis, Prognosis, and Therapy Response in Lung Cancer. Diagnostics [Internet]. 2021 Mar 1 [cited 2025 Aug 8];11(3):421. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7999833\/","DOI":"10.3390\/diagnostics11030421"},{"key":"11543_CR7","doi-asserted-by":"crossref","unstructured":"Gilyazova I, Asadullina D, Kagirova E, Sikka R, Mustafin A, Ivanova E et al (2023) MiRNA-146a\u2014A Key Player in Immunity and Diseases. Int J Mol Sci [Internet]. Aug 1 [cited 2025 Oct 8];24(16):12767. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10454149\/","DOI":"10.3390\/ijms241612767"},{"key":"11543_CR8","doi-asserted-by":"crossref","unstructured":"Chafin CB, Reilly CM (2013) MicroRNAs Implicated in the Immunopathogenesis of Lupus Nephritis. Clin Dev Immunol [Internet]. [cited 2025 Dec 9];2013:430239. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3741610\/","DOI":"10.1155\/2013\/430239"},{"key":"11543_CR9","doi-asserted-by":"crossref","unstructured":"R\u00eago Muniz MP, Fechine Brito LPA, Cavalcante Vale PH, Guedes FL, Mendon\u00e7a Oliveira TK, de Ara\u00fajo Brito DJ et al Renal involvement in systemic lupus erythematosus: additional histopathological lesions. Archives of Medical Science [Internet]. 2023 Sep 1 [cited 2026 Jan 29];19(5):1398\u2013409. Available from: https:\/\/www.archivesofmedicalscience.com\/Renal-involvement-in-systemic-lupus-erythematosus-additional-histopathological-lesions,122684,0,2.html","DOI":"10.5114\/aoms.2020.96617"},{"key":"11543_CR10","doi-asserted-by":"crossref","unstructured":"El-Akhras BA, Talaat RM, El-Masry SA, Bassyouni IH, El-Sayed IH, Ali YBM (2023) Crosstalk between miR-146a and pro-inflammatory cytokines in patients with systemic lupus erythematosus. Int J Immunopathol Pharmacol [Internet]. Jan 1 [cited 2025 Oct 8];37:03946320231154998. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9903020\/","DOI":"10.1177\/03946320231154998"},{"key":"11543_CR11","doi-asserted-by":"publisher","first-page":"1442013","DOI":"10.3389\/flupu.2024.1442013","volume":"2","author":"C Lau","year":"2024","unstructured":"Lau C, Leandro M, Flower CH, Lin A, Wakhlu A, Connelly K (2024) Disease activity assessment in systemic lupus erythematosus. Front Lupus 2:1442013","journal-title":"Front Lupus"},{"key":"11543_CR12","doi-asserted-by":"crossref","unstructured":"Choi D, Kim J, Yang JW, Kim JH, Park S, Shin J, Il Dysregulated MicroRNAs in the Pathogenesis of Systemic Lupus Erythematosus: A Comprehensive Review. Int J Biol Sci [Internet]. 2023 [cited 2025 Oct 8];19(8):2495. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10197884\/","DOI":"10.7150\/ijbs.74315"},{"key":"11543_CR13","doi-asserted-by":"crossref","unstructured":"El-Akhras BA, Ali YBM, El-Masry SA, Bassyouni IH, El-Sayed IH, Talaat RM (2022) mir-146a genetic polymorphisms in systemic lupus erythematosus patients: Correlation with disease manifestations. Noncoding RNA Res [Internet]. Sep 1 [cited 2025 Oct 8];7(3):142. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9192690\/","DOI":"10.1016\/j.ncrna.2022.05.001"},{"key":"11543_CR14","doi-asserted-by":"crossref","unstructured":"Fan Y, Ji Y, Wang X, Hu J, Zhang Q, Xu J et al Relationship of miRNA-146a to systemic lupus erythematosus: A PRISMA-compliant meta-analysis. Medicine [Internet]. 2020 Oct 2 [cited 2025 Oct 8];99(40):e22444. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7535641\/","DOI":"10.1097\/MD.0000000000022444"},{"key":"11543_CR15","doi-asserted-by":"crossref","unstructured":"Singh RP, Hahn BH, Bischoff DS (2022) Identification and Contribution of Inflammation-Induced Novel MicroRNA in the Pathogenesis of Systemic Lupus Erythematosus. Front Immunol [Internet]. Apr 4 [cited 2025 Dec 9];13:848149. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9013931\/","DOI":"10.3389\/fimmu.2022.848149"},{"key":"11543_CR16","doi-asserted-by":"crossref","unstructured":"ElFeky DS, Omar NM, Shaker OG, Abdelrahman W, Gheita TA, Nada MG (2024) Circulatory microRNAs and proinflammatory cytokines as predictors of lupus nephritis. Front Immunol [Internet]. [cited 2025 Oct 8];15:1449296. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11502402\/","DOI":"10.3389\/fimmu.2024.1449296"},{"key":"11543_CR17","doi-asserted-by":"crossref","unstructured":"Choi D, Kim J, Yang JW, Kim JH, Park S, Shin J, Il Dysregulated MicroRNAs in the Pathogenesis of Systemic Lupus Erythematosus: A Comprehensive Review. Int J Biol Sci [Internet]. 2023 [cited 2025 Oct 9];19(8):2495. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10197884\/","DOI":"10.7150\/ijbs.74315"},{"key":"11543_CR18","doi-asserted-by":"publisher","unstructured":"Vieira AA, Almada-Correia I, In\u00e1cio J, Costa-Reis P, da Rocha ST Female-bias in systemic lupus erythematosus: How much is the X chromosome to blame? Biology of Sex Differences 2024 15:1 [Internet]. 2024 Oct 7 [cited 2025 Aug 23];15(1):1\u201315. Available from: https:\/\/bsd.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s13293-024-00650-y","DOI":"10.1186\/s13293-024-00650-y"},{"key":"11543_CR19","doi-asserted-by":"publisher","unstructured":"Mongkolchaiarunya J, Wongthanee A, Kasitanon N, Louthrenoo W Comparison of clinical features, disease activity, treatment and outcomes between late-onset and early-onset patients with systemic lupus erythematosus. A sex- and year at diagnosis-matched controlled study. Advances in Rheumatology [Internet]. 2023 Dec 1 [cited 2025 Aug 23];63(1):1\u201310. Available from: https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s42358-023-00297-0","DOI":"10.1186\/s42358-023-00297-0"},{"key":"11543_CR20","doi-asserted-by":"crossref","unstructured":"Aringer M, Arnaud L, Furie RA, Morand EF, Peschken C, Hoi A et al Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS). Lupus Sci Med [Internet]. 2025 Jan [cited 2025 Aug 23];12(1):e001336. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39855677\/","DOI":"10.1136\/lupus-2024-001336"},{"key":"11543_CR21","doi-asserted-by":"crossref","unstructured":"Ben Mrid R, Bouchmaa N, Ainani H, El Fatimy R, Malka G, Mazini L Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis. Biomedicine & Pharmacotherapy [Internet]. 2022 Jul 1 [cited 2026 Jan 30];151:113126. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0753332222005157","DOI":"10.1016\/j.biopha.2022.113126"},{"key":"11543_CR22","doi-asserted-by":"crossref","unstructured":"Li N, Hoi A, Luo SF, Wu YJJ, Louthrenoo W, Golder V et al Time trends of variability in disease activity in systemic lupus erythematosus. Lupus Sci Med [Internet]. 2025 Feb 12 [cited 2025 Aug 23];12(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39939124\/","DOI":"10.1136\/lupus-2024-001335"},{"key":"11543_CR23","doi-asserted-by":"crossref","unstructured":"Xiang Y, Zhang M, Jiang D, Su Q, Shi J (2023) The role of inflammation in autoimmune disease: a therapeutic target. Frontiers in Immunology, vol 14. Frontiers Media SA","DOI":"10.3389\/fimmu.2023.1267091"},{"key":"11543_CR24","doi-asserted-by":"crossref","unstructured":"Coss SL, Zhou D, Chua GT, Aziz RA, Hoffman RP, Wu YL et al (2023) The complement system and human autoimmune diseases. J Autoimmun [Internet]. May 1 [cited 2025 Oct 9];137:102979. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0896841122001871","DOI":"10.1016\/j.jaut.2022.102979"},{"key":"11543_CR25","doi-asserted-by":"crossref","unstructured":"K\u0105dziela M, Fija\u0142kowska A, Kraska-Gacka M, Wo\u017aniacka A (2077) The Art of Interpreting Antinuclear Antibodies (ANAs) in Everyday Practice. Journal of Clinical Medicine 2025, Vol 14, Page 5322 [Internet]. 2025 Jul 28 [cited 2025 Oct 9];14(15):5322. Available from: https:\/\/www.mdpi.com\/-0383\/14\/15\/5322\/htm","DOI":"10.3390\/jcm14155322"},{"key":"11543_CR26","unstructured":"Zheng C, Sun Z, Wang J, Wang Y, Xiang M, Gao Z et al Identification and experimental validation of glycosylation related differentially expressed genes as diagnostic biomarkers in systemic lupus erythematosus. Scientific Reports 2025 15:1 [Internet]. 2025 Nov 19 [cited 2026 Jan 30];15(1):40694-. Available from: https:\/\/www.nature.com\/articles\/s41598-025-24401-0"},{"key":"11543_CR27","doi-asserted-by":"crossref","unstructured":"Wang S, Wang F, Wang X, Zhang Y, Song L (2021) Elevated Creatinine Clearance in Lupus Nephritis patients with Normal Creatinine. Int J Med Sci [Internet]. [cited 2025 Aug 23];18(6):1449. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7893553\/","DOI":"10.7150\/ijms.51117"},{"key":"11543_CR28","unstructured":"Musa R, Rout P, Qurie A (2025) Lupus Nephritis. StatPearls [Internet]. Jan 16 [cited 2026 Jan 29]; Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK499817\/"},{"key":"11543_CR29","doi-asserted-by":"publisher","unstructured":"Yadav I, Arora R, Zaheer S, Yadav R The diagnostic utility of Ana, dsDNA and complement levels in patient with suspected autoimmune disease. International Journal of Clinical and Diagnostic Pathology [Internet]. 2020 [cited 2025 Aug 23];3(1):138\u201340. Available from: https:\/\/doi.org\/10.33545\/pathol.2020.v3.i1c.164","DOI":"10.33545\/pathol.2020.v3.i1c.164"},{"key":"11543_CR30","doi-asserted-by":"crossref","unstructured":"Zhao J, Peng W, Wu S, Wang W Evaluation of disease activity in systemic lupus erythematosus using standard deviation of lymphocyte volume combined with red blood cell count and lymphocyte percentage. Scientific Reports 2024 14:1 [Internet]. 2024 Sep 28 [cited 2026 Jan 29];14(1):22470-. Available from: https:\/\/www.nature.com\/articles\/s41598-024-72977-w","DOI":"10.1038\/s41598-024-72977-w"},{"key":"11543_CR31","unstructured":"Ray R, Shende V, Sukul S Association between inflammatory markers (CRP, ESR) and MRI findings in rheumatoid arthritis. European Journal of Cardiovascular Medicine [Internet]. 2025 Jul 26 [cited 2025 Aug 23];15:716\u201320. Available from: https:\/\/healthcare-bulletin.co.uk\/article\/association-between-inflammatory-markers-crp-esr-and-mri-findings-in-rheumatoid-arthritis-3881\/"},{"key":"11543_CR32","doi-asserted-by":"crossref","unstructured":"Mostafa E, Mohammed HF, Mohammed EM, Ali ASM Inflammatory markers and fever in SLE patients. Minia Journal of Medical Research [Internet]. 2022 Apr 1 [cited 2025 Aug 23];33(2):59\u201361. Available from: https:\/\/mjmr.journals.ekb.eg\/article_249061.html","DOI":"10.21608\/mjmr.2022.249061"},{"key":"11543_CR33","doi-asserted-by":"crossref","unstructured":"Chi M, Ma K, Li Y, Quan M, Han Z, Ding Z et al Immunological Involvement of MicroRNAs in the Key Events of Systemic Lupus Erythematosus. Front Immunol [Internet]. 2021 Aug 2 [cited 2025 Aug 23];12:699684. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8365877\/","DOI":"10.3389\/fimmu.2021.699684"},{"key":"11543_CR34","doi-asserted-by":"crossref","unstructured":"ElFeky DS, Omar NM, Shaker OG, Abdelrahman W, Gheita TA, Nada MG (2024) Circulatory microRNAs and proinflammatory cytokines as predictors of lupus nephritis. Front Immunol [Internet]. [cited 2025 Oct 9];15:1449296. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11502402\/","DOI":"10.3389\/fimmu.2024.1449296"},{"key":"11543_CR35","doi-asserted-by":"crossref","unstructured":"El-Akhras BA, Ali YBM, El-Masry SA, Bassyouni IH, El-Sayed IH, Talaat RM (2022) mir-146a genetic polymorphisms in systemic lupus erythematosus patients: Correlation with disease manifestations. Noncoding RNA Res [Internet]. Sep 1 [cited 2025 Oct 9];7(3):142. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9192690\/","DOI":"10.1016\/j.ncrna.2022.05.001"},{"key":"11543_CR36","doi-asserted-by":"crossref","unstructured":"Gong F, Li X, Zhang H, Wu J, Ma G, Zhang B et al (2022) MiR-192-5p Alleviated Fibrosis and Inflammatory Responses of Tendon Cells by Targeting NFAT5. Comput Math Methods Med [Internet]. [cited 2025 Oct 9];2022:6481846. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9276496\/","DOI":"10.1155\/2022\/6481846"},{"key":"11543_CR37","doi-asserted-by":"publisher","unstructured":"Yang Y, Razak SRA, Ismail IS, Ma Y, Yunus MA Molecular mechanisms of miR-192 in cancer: a biomarker and therapeutic target. Cancer Cell International [Internet]. 2025 Dec 1 [cited 2025 Oct 9];25(1):1\u201319. Available from: https:\/\/cancerci.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12935-025-03666-5","DOI":"10.1186\/s12935-025-03666-5"},{"key":"11543_CR38","doi-asserted-by":"crossref","unstructured":"Garmaa G, Nagy R, K\u00f3i T, To UN, Do, Gerg\u0151 D, Kleiner D et al Panel miRNAs are potential diagnostic markers for chronic kidney diseases: a systematic review and meta-analysis. BMC Nephrol [Internet]. 2024 Dec 1 [cited 2026 Jan 30];25(1):261. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11323638\/","DOI":"10.1186\/s12882-024-03702-y"},{"key":"11543_CR39","doi-asserted-by":"crossref","unstructured":"Gilyazova I, Asadullina D, Kagirova E, Sikka R, Mustafin A, Ivanova E et al (2023) MiRNA-146a\u2014A key player in immunity and diseases. Int J Mol Sci. ;24(16)","DOI":"10.3390\/ijms241612767"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11543-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11543-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11543-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:03:44Z","timestamp":1773147824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11543-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11543"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11543-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research protocol was approved by the ethical guidelines of MUST University Ethics Committee (FWA00025577).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}}],"article-number":"481"}}